{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:09:35Z","timestamp":1789657775662,"version":"4.0.1"},"reference-count":21,"publisher":"Society of Nuclear Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,3,25]]},"published-print":{"date-parts":[[2026,9]]},"DOI":"10.2967\/jnumed.125.271705","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:15:14Z","timestamp":1776870914000},"page":"1448-1451","source":"Crossref","is-referenced-by-count":0,"title":["[\n                    <sup>177<\/sup>\n                    Lu]Lu-AKIR001 for CD44v6-Positive Pancreatic Cancer: Preclinical Efficacy and Combination Strategies"],"prefix":"10.2967","volume":"67","author":[{"given":"Amanda","family":"Gustafsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedvig","family":"Svedberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara S.","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippa","family":"Bertilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram Kumar","family":"Selvaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja C.","family":"Lundgren Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Lindskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Nestor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"2026091707501243000_67.9.1448.1","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v12.i2.173"},{"key":"2026091707501243000_67.9.1448.2","unstructured":"Cancer facts and figures 2024. American Cancer Society website. https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/2024-cancer-facts-figures.html. Accessed April 6, 2026."},{"key":"2026091707501243000_67.9.1448.3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.612271"},{"key":"2026091707501243000_67.9.1448.4","doi-asserted-by":"crossref","first-page":"10124","DOI":"10.3748\/wjg.v22.i46.10124","article-title":"Dilemma of first line regimens in metastatic pancreatic adenocarcinoma","volume":"22","author":"Ghosn","year":"2016","journal-title":"World J Gastroenterol."},{"key":"2026091707501243000_67.9.1448.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011923"},{"key":"2026091707501243000_67.9.1448.6","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj941"},{"key":"2026091707501243000_67.9.1448.7","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E14-04-0916"},{"key":"2026091707501243000_67.9.1448.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.190124"},{"key":"2026091707501243000_67.9.1448.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.270782"},{"key":"2026091707501243000_67.9.1448.10","doi-asserted-by":"publisher","DOI":"10.1080\/01926230490465874"},{"key":"2026091707501243000_67.9.1448.11","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-014-0054-2"},{"key":"2026091707501243000_67.9.1448.12","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.3390\/ijms19102979","article-title":"efficacy evaluation of combination treatment using gemcitabine and radioimmunotherapy with 90Y-labeled fully human anti-CD147 monoclonal Antibody 059-053 in a BxPC-3 xenograft mouse model of refractory pancreatic cancer","volume":"19","author":"Sugyo","year":"2018","journal-title":"Int J Mol Sci."},{"key":"2026091707501243000_67.9.1448.13","doi-asserted-by":"publisher","DOI":"10.1007\/s002800050492"},{"key":"2026091707501243000_67.9.1448.14","first-page":"716","article-title":"Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model","volume":"47","author":"Kelly","year":"2006","journal-title":"J Nucl Med."},{"key":"2026091707501243000_67.9.1448.15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1159\/000434723","article-title":"Pancreatic neuroendocrine tumor control: durable objective response to combination 177Lu-octreotate-capecitabine-temozolomide radiopeptide chemotherapy","volume":"103","author":"Claringbold","year":"2016","journal-title":"Neuroendocrinology."},{"key":"2026091707501243000_67.9.1448.16","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2012.1276"},{"key":"2026091707501243000_67.9.1448.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.269252"},{"key":"2026091707501243000_67.9.1448.18","doi-asserted-by":"crossref","first-page":"848.e9","DOI":"10.1016\/j.urolonc.2020.05.028","article-title":"Phase I trial of docetaxel plus lutetium-177-labeled anti\u2013prostate\u2010specific membrane antigen monoclonal antibody J591 (177Lu\u2010J591) for metastatic castration\u2010resistant prostate cancer","volume":"38","author":"Batra","year":"2020","journal-title":"Urol Oncol."},{"key":"2026091707501243000_67.9.1448.19","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0048"},{"key":"2026091707501243000_67.9.1448.20","doi-asserted-by":"crossref","first-page":"109012","DOI":"10.1016\/j.nucmedbio.2025.109012","article-title":"Affinity maturation and optimization of CD44v6-targeting antibodies for molecular radiotherapy","volume":"144-145","author":"Mortensen","year":"2025","journal-title":"Nucl Med Biol."},{"key":"2026091707501243000_67.9.1448.21","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/jlcr.3628","article-title":"Understanding the in\u00a0vivo fate of radioimmunoconjugates for nuclear imaging","volume":"61","author":"Vivier","year":"2018","journal-title":"J Labelled Comp Radiopharm."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.271705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:51:10Z","timestamp":1789656670000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.271705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":21,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,2]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.2967\/jnumed.125.271705"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.271705","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]}}}